- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Boule Diagnostics AB (BOUL)
Track the Boule Diagnostics share price today and view real-time BOUL share price data, including charts, technicals, and key financials. View the BOUL premarket stock price ahead of the market session or assess the after hours quote. Explore BOUL stock price movements, trading volume, and market activity across the ST exchange.
What Is the Boule Diagnostics Stock Price Today?
The Boule Diagnostics stock price today is 3.38.
What Is the Stock Symbol for Boule Diagnostics?
The stock symbol for Boule Diagnostics is ""BOUL.""
What Stock Exchange Does Boule Diagnostics Trade On?
Boule Diagnostics is listed and trades on the Stockholm stock exchange.
Is Boule Diagnostics a Good Stock to Buy?
Determining whether Boule Diagnostics or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BOUL quote. (ISIN: SE0011231158)
What Is the Boule Diagnostics Stock Price Today?
The Boule Diagnostics stock price today is 3.38.
What Is the Stock Symbol for Boule Diagnostics?
The stock symbol for Boule Diagnostics is ""BOUL.""
What Stock Exchange Does Boule Diagnostics Trade On?
Boule Diagnostics is listed and trades on the Stockholm stock exchange.
Is Boule Diagnostics a Good Stock to Buy?
Determining whether Boule Diagnostics or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BOUL quote. (ISIN: SE0011231158)
Stockholm
Currency in SEK
3.38
-0.37(-9.87%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.75
3.71
52 wk Range
2.75
9.30
Earnings results expected today
1/4
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.753.71
52 wk Range
2.759.30
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BOUL Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Neutral
Price Target
3.80
Upside
+12.43%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
- Enzymatica appoints Holger Lembrér as new CFO
- Investing.com
- Enzymatica appoints Holger Lembrér as new CFO
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 3.80
(+12.43% Upside)
Boule Diagnostics AB Earnings Call Summary for Q2/2026
- Boule Diagnostics Q2 sales fell 13% to SEK 112M; adjusted EBIT dropped 25% to SEK 3.3M amid currency headwinds and weak diagnostics demand.
- Gross margin improved 2.2 points to 40.9% on better product mix; operating cash flow turned negative at SEK 1.5M after four positive quarters.
- Diagnostics segment declined 17.9% while OEM business showed recovery with 7.6% organic growth and margins doubling to 32% year-over-year.
- Shares plunged 12.8% to $3.27, nearing 52-week low, as geopolitical disruptions and tight liquidity (SEK 26.2M) pressured results.
- CEO expects H2 improvement from upcoming procurements and distributor restocking; no numerical guidance issued but focus remains on cash flow restoration.
Last Updated: 17/07/2026, 11:26 pm
Read Full TranscriptEarnings
Latest Release
28/04/2026
EPS / Forecast
-0.38 / --
Revenue / Forecast
101.6M / --
Compare BOUL to Peers and Sector
Metrics to compare | BOUL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBOULPeersSector | |
|---|---|---|---|---|
P/E Ratio | −18.1x | 26.6x | −0.4x | |
PEG Ratio | −0.19 | −0.17 | 0.00 | |
Price/Book | 0.8x | 1.9x | 2.6x | |
Price / LTM Sales | 0.3x | 3.1x | 3.1x | |
Upside (Analyst Target) | 1.3% | 0.4% | 50.8% | |
Fair Value Upside | Unlock | 15.9% | 7.8% | Unlock |
Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East. It operates through Diagnostics and OEM Clinical Diagnostic Solutions. The company provides hematology analyzers, reagents, controls, and calibrators, under the Swelab, and Medonic brands; and veterinary hematology and clinical chemistry analyzer systems, as well as reagents and panels under the Exigo brand. It serves small and medium-sized hospitals, clinics, laboratories, and veterinary clinics, and other diagnostics firms. The company was founded in 1956 and is headquartered in Spånga, Sweden.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Boule Diagnostics (BOUL) Stock Price Today?
The Boule Diagnostics stock price today is 3.38 SEK.
What Stock Exchange Does Boule Diagnostics Trade On?
Boule Diagnostics is listed and trades on the Stockholm Stock Exchange.
What Is the Stock Symbol for Boule Diagnostics?
The stock symbol for Boule Diagnostics is "BOUL."
What Is the Boule Diagnostics Market Cap?
As of today, Boule Diagnostics market cap is 131.26M SEK.
What Is Boule Diagnostics's Earnings Per Share (TTM)?
The Boule Diagnostics EPS (TTM) is -0.21.
When Is the Next Boule Diagnostics Earnings Date?
Boule Diagnostics will release its next earnings report on 17/07/2026.
From a Technical Analysis Perspective, Is BOUL a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Boule Diagnostics Stock Split?
Boule Diagnostics has split 1 times.
How Many Employees Does Boule Diagnostics Have?
Boule Diagnostics has 200 employees.
What is the current trading status of Boule Diagnostics (BOUL)?
As of 17/07/2026, Boule Diagnostics (BOUL) is trading at a price of 3.38 SEK, with a previous close of 3.75 SEK. The stock has fluctuated within a day range of 2.75 SEK to 3.71 SEK, while its 52-week range spans from 2.75 SEK to 9.30 SEK.
What Is Boule Diagnostics (BOUL) Price Target According to Analysts?
The average 12-month price target for Boule Diagnostics is 3.80 SEK, with a high estimate of 3.8 SEK and a low estimate of 3.8 SEK. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an +12.43% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.